Polycystic ovary syndrome: a reproductive and metabolic web of risk, comorbidities, and disease

被引：5
作者：
Bates, G. Wright, Jr. [1 ]
机构：
[1] Baylor Scott & White, Dept Obstet & Gynecol, Temple, TX 76508 USA
来源：
FERTILITY AND STERILITY | 2019年 / 111卷 / 03期
关键词：
HIGH BLOOD-PRESSURE; WOMEN;
D O I：
10.1016/j.fertnstert.2019.01.028
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：471 / 472
页数：2
相关论文
共 50 条
  • [21] Interventions for the metabolic dysfunction in polycystic ovary syndrome
    Bozdag, Gurkan
    Yildiz, Bulent O.
    STEROIDS, 2013, 78 (08) : 777 - 781
  • [22] Metabolic Deregulations in Patients with Polycystic Ovary Syndrome
    Jabczyk, Marzena
    Nowak, Justyna
    Jagielski, Pawel
    Hudzik, Bartosz
    Kulik-Kupka, Karolina
    Wlodarczyk, Aleksander
    Lar, Katarzyna
    Zubelewicz-Szkodzinska, Barbara
    METABOLITES, 2023, 13 (02)
  • [23] Can environmental pollutant bisphenol A increase metabolic risk in polycystic ovary syndrome?
    Milanovic, Maja
    Milosevic, Natasa
    Sudji, Jan
    Stojanoski, Stefan
    Krstonosic, Milica Atanackovic
    Bjelica, Artur
    Milic, Natasa
    Stojanoska, Milica Medic
    CLINICA CHIMICA ACTA, 2020, 507 : 257 - 263
  • [24] Racial and Ethnic Differences in Metabolic Disease in Adolescents With Obesity and Polycystic Ovary Syndrome
    Andrisse, Stanley
    Garcia-Reyes, Yesenia
    Pyle, Laura
    Kelsey, Megan M.
    Nadeau, Kristen J.
    Cree-Green, Melanie
    JOURNAL OF THE ENDOCRINE SOCIETY, 2021, 5 (04)
  • [25] Cardiovascular disease in polycystic ovary syndrome
    Atkin, S. L.
    CLINICAL ENDOCRINOLOGY, 2013, 78 (06) : 823 - 824
  • [26] Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome
    Krentowska, Anna
    Lebkowska, Agnieszka
    Jacewicz-Swiecka, Malgorzata
    Hryniewicka, Justyna
    Lesniewska, Monika
    Adamska, Agnieszka
    Kowalska, Irina
    ENDOCRINE, 2021, 72 (02) : 400 - 410
  • [27] Nonalcoholic fatty liver disease risk in polycystic ovary syndrome patients
    Fernandez-Alonso, Ana M.
    Chedraui, Peter
    Perez-Lopez, Faustino R.
    GYNECOLOGICAL ENDOCRINOLOGY, 2024, 40 (01)
  • [28] Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention
    Osibogun, Olatokunbo
    Ogunmoroti, Oluseye
    Michos, Erin D.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2020, 30 (07) : 399 - 404
  • [29] Polycystic ovary syndrome: a "risk-enhancing"factor for cardiovascular disease
    Guan, Carolyn
    Zahid, Salman
    Minhas, Anum S.
    Ouyang, Pamela
    Vaught, Arthur
    Baker, Valerie L.
    Michos, Erin D.
    FERTILITY AND STERILITY, 2022, 117 (05) : 924 - 935
  • [30] Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
    Choudhari, Rutuja
    Tayade, Surekha
    Tiwari, Aakriti
    Satone, Prasiddhi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
12345